v3.26.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 1,860,000 $ 1,337,000
Accrued expenses 1,037,000 839,000
Stock compensation 2,239,000 1,927,000
Capitalized R&D costs, net 308,000
Intangible asset, net 508,000 508,000
Accrued interest 5,000 4,000
Subtotal 5,649,000 4,923,000
Less valuation allowance (5,649,000) (4,923,000)
Net deferred tax asset $ 0 $ 0